Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2025)

Abeona Therapeutics has reported Interest Income - Net over the past 5 years, most recently at $663000.0 for Q4 2025.

  • Quarterly results put Interest Income - Net at $663000.0 for Q4 2025, up 1223.73% from a year ago — trailing twelve months through Dec 2025 was $1.8 million (up 4678.95% YoY), and the annual figure for FY2025 was $1.8 million, up 4678.95%.
  • Interest Income - Net for Q4 2025 was $663000.0 at Abeona Therapeutics, down from $771000.0 in the prior quarter.
  • Over the last five years, Interest Income - Net for ABEO hit a ceiling of $771000.0 in Q3 2025 and a floor of -$676000.0 in Q3 2021.
  • Median Interest Income - Net over the past 5 years was $103000.0 (2024), compared with a mean of $140611.1.
  • Biggest five-year swings in Interest Income - Net: crashed 141.44% in 2024 and later skyrocketed 1223.73% in 2025.
  • Abeona Therapeutics' Interest Income - Net stood at -$48000.0 in 2021, then skyrocketed by 412.5% to $150000.0 in 2022, then soared by 322.67% to $634000.0 in 2023, then plummeted by 109.31% to -$59000.0 in 2024, then skyrocketed by 1223.73% to $663000.0 in 2025.
  • The last three reported values for Interest Income - Net were $663000.0 (Q4 2025), $771000.0 (Q3 2025), and $70000.0 (Q2 2025) per Business Quant data.